Actively enrolling · 6 studies open
24/7 enrollment line386-218-5911
30+
Years site operating
80+
Completed trials
1,200+
Subjects enrolled
<2 wks
Typical IRB turnaround
Therapeutic experience

Indications we've run, by area.

Our team has conducted Phase I–IV studies across the areas below. Earlier-phase and first-in-human studies are conducted at our dedicated Phase I unit; Phase II–IV and observational studies run out of the main site.

Endocrinology & Metabolic
diabetes, obesity, thyroid
Pulmonology
asthma, COPD, interstitial lung disease
Psychiatry
depression, anxiety, PTSD
Cardiovascular
heart failure, AFib, hypertension
Pediatric Endocrinology
ISS growth, Type 1 diabetes
Rheumatology
rheumatoid arthritis, psoriatic arthritis
Dermatology
atopic dermatitis, psoriasis
Infectious Disease
vaccines, antivirals
Nephrology
Neurology
Investigator network

Multi-specialty principal investigators.

Protocols are matched to the right clinical specialty and surrounded by centralized ORS operational support — startup, regulatory, recruitment, and study conduct.

Dr. Kristyna Paradis

Emergency Medicine / Internal Medicine

Dr. Antonio Cubano

Psychiatry

Dr. Catherine Arevalo

Internal Medicine

Dr. David Riascos

Internal Medicine / Neuroscience

Dr. Jaqueline Freyre

Pediatrics

Dr. Lorna Bennett

Pediatrics

Dr. Penelope Pauley

Pediatric Endocrinology

Dr. Vincent Do

Optometry

Dr. Ross Wheeler

Dermatopathology

Dr. Adly Thebaud, CPI

Psychiatry

Kimberlee Del Campo, APRN, NP-C, APIPC

Advanced Practice Investigator / Clinical Director

What makes us different

Six reasons sponsors come back.

On-site Phase I unit

9-bed inpatient facility (DeBary, FL) with 24-hour medical coverage, dialysis-capable treatment beds, and separate male/female accommodations. Purpose-built for early-phase protocols that other sites have to refer out.

In-house regulatory

Dedicated regulatory team handles IRB submission, amendment management, SAE and AE reporting, and monitor support without outsourcing. Monitor visits see source documentation maintained to sponsor standards.

Certified sample processing

On-site sample lab with refrigerated centrifuges, −70°C and −20°C storage, and computerized EKG. Most protocols avoid off-site sample routing entirely, preserving sample integrity and shortening turnaround.

Diverse recruitment pool

Central Florida location at the intersection of Orlando International and Sanford International airports. Bilingual English / Spanish team supports a demographically diverse participant base most single-site operations cannot match.

Retention program

Dedicated coordinator-to-participant relationships, on-site amenities (WiFi, streaming, quiet rooms), and travel reimbursement reduce drop-out across long-duration protocols — including oncology, rheumatology, and cardiovascular studies.

Rapid activation

Typical IRB turnaround under two weeks for amendments, with full study activation achievable inside 30 days of final protocol. GCP-trained staff ready on day one.

Let's talk

Qualify the site for your next protocol.

Send us a feasibility questionnaire or jump on a 30-minute call. We can turn around a site capability questionnaire inside 48 hours and coordinate a site visit within two weeks.